Fair Value Calculator Fair Value Calculator
EN DE

CAPILLARY (CAPILLARY) Fair Value & Analysis

Technology · Market cap ₹40.4B

C CAPILLARY CAPILLARY · NSE
Price₹508.15
Fair Value₹112.06
Upside-77.9%
Quality41/100
Watch CAPILLARY for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹84.05 – ₹140.08

Fair value as of: Jul 3, 2026

From 14 valuation models · updated today

Share price −0.5% over the past month.

Price vs Fair Value (7 months)

₹732.15 ₹471.00 Fair Value ₹112.06 Nov 2025 Jul 2026

7‑month range ₹471.00 – ₹732.15 · fair‑value band ₹84.05 – ₹140.08 · the ₹508.15 price screens above the ₹112.06 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CAPILLARY (CAPILLARY) currently trades at ₹508.15, while our model-based Fair Value estimate is ₹112.06 — implying the stock looks roughly 77.9% overvalued today. We read business quality at 41/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, CAPILLARY generated revenue of ₹7.3B at a net margin of 7.1%. Revenue grew 25.8% year over year. It earns a return on equity of 6.6%. Net debt stands at ₹89.1M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹7.3B
Revenue growth (YoY) +25.8%
Net margin 7.1%
Return on equity 6.6%
Free cash flow −₹2.1B FY2026
P/E ratio 73.8
More key figures
Operating margin 9.7%
EPS (TTM) ₹6.89
EPS growth (YoY) +306%
Net debt ₹89.1M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2023 – FY2026 · reported fiscal years

CAPILLARY reported revenue of ₹7.3B in FY2026 versus ₹2.6B in FY2023, a compound +42.2%/yr. Reported net income was ₹524M in FY2026.

Revenue +42.2%/yr
FY23 ₹2.6B
FY24 ₹5.3B
FY25 ₹6.0B
FY26 ₹7.3B
Net income
FY23 −₹877M
FY24 −₹594M
FY25 ₹133M
FY26 ₹524M

Is CAPILLARY fairly valued? → Check now

Similar stocks

6 more Software - Infrastructure stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Microsoft Corporation MSF €379.75 €183.26 -52%
MSFT MSFT 7,019 MXN 3,725 MXN -47%
Oracle Corporation ORCL $175.07 $68.15 -61%
Palantir Technologies Inc PTX €107.36 €20.73 -81%
Palo Alto Networks, Inc 5AP €227.65 €26.66 -88%
CrowdStrike Holdings CRWD C$53.33 C$6.32 -88%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CAPILLARY (CAPILLARY) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹112.06 versus a price of ₹508.15 — about −78% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CAPILLARY?
Our model-based fair value for CAPILLARY is ₹112.06 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹508.15.
What is the quality score of CAPILLARY?
CAPILLARY has a Quality Score of 41/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CAPILLARY (CAPILLARY)?
CAPILLARY reported trailing-twelve-month revenue of about ₹7.3B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of CAPILLARY?
The net profit margin of CAPILLARY is about 7.1%, meaning it keeps roughly 7.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.